MYCN and neuroblastoma: Risk stratification is multifactorial, considering the International Neuroblastoma Risk Group (INRG) tumour stage, patient age at diagnosis, tumour histology, differentiation, MYCN status, DNA ploidy and chromosomal imbalances.